Off-Patent Industry Calls For Security Of Supply Legislation In EU
Increasing Inflation And Potential Price Cuts Could Impede Access
Executive Summary
Medicines for Europe has urged the European Commission to enshrine security of supply considerations for essential medicines into legislation. Without these, it says, additional cost containment measures for off-patent medicines under consideration by member states could threaten access by making production unsustainable for manufacturers.